Skip to Main Content

By watching the video above, join a first of its kind discussion with Black CEOs of biotechnology companies and leaders of BIO about their unique perspectives on being pioneers in developing medicines. Topics include business priorities, advancing diversity in clinical trials, and the disproportionate impact of COVID-19 on underrepresented populations.


  • Michelle McMurry-Heath, MD, PhD, President and Chief Executive Officer, Biotechnology Innovation Organization
  • Tony Coles, MD, Chief Executive Officer and Chairperson of the Board of Directors, Cerevel Therapeutics, LLC
  • Jeremy Levin, MB BChir, D. Phil, Chairman of the Board of Directors and Chief Executive Officer, Ovid Therapeutics Inc. • Ted Love, MD, President & Chief Executive Officer, Global Blood Therapeutics